Before you begin using a medication, be sure to inform your doctor of any medical conditions or Allergies you may have, any medications you are taking, whether you are pregnant or breast-feeding, and any other significant facts about your health. These factors may affect how you should use Remodulin (Treprostinil).
Infection: Since Remodulin (Treprostinil) is given intravenously and usually for a long period of time through a central venous catheter, this increases your risk of infections in the blood, which can be fatal.
If you notice any signs or symptoms such as a sudden onset of fever, fatigue, or headache, contact your doctor immediately. Giving the medication intravenously also puts you at increased risk of infections at the infusion site. Contact your doctor as soon as possible if you notice symptoms such as redness, tenderness, swelling, or pus at the infusion site.
Kidney or liver disease: If you have kidney or liver disease, discuss with your doctor how Remodulin (Treprostinil) may affect your medical condition, how your medical condition may affect the dosing and effectiveness of Remodulin (Treprostinil), and whether any special monitoring is needed.
Stopping the medication: Stopping Remodulin (Treprostinil) abruptly or sudden large decreases in the dose can result in symptoms of pulmonary hypertension such as pain when breathing (dyspnea), dizziness, weakness, and fatigue. If your Remodulin (Treprostinil) is stopped abruptly for some reason and you develop these symptoms, contact your doctor immediately.
Pregnancy: Remodulin (Treprostinil) should not be used during pregnancy unless the benefits outweigh the risks. If you become pregnant while taking Remodulin (Treprostinil), contact your doctor immediately.
Breast-feeding: It is not known if Remodulin (Treprostinil) passes into breast milk. If you are a breast-feeding mother and are taking Remodulin (Treprostinil), it may affect your baby. Talk to your doctor about whether you should continue breast-feeding.
Children: The safety and effectiveness of using Remodulin (Treprostinil) have not been established for children under 16 years of age.
Seniors: The safety and effectiveness of using Remodulin (Treprostinil) have not been established for people above 65 years of age.